References
- Akerstedt T. (2003). Shift work and disturbed sleep/wakefulness. Occup Med. 53:89–94.
- Faraut B, Boudjeltia KZ, Vanhamme L, et al. (2012). Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery. Sleep Med Rev. 16:137–149.
- Ferrie JE, Kivimäki M, Akbaraly TN, et al. (2013). Associations between change in sleep duration and inflammation: Findings on C-reactive protein and interleukin 6 in the Whitehall II Study. Am J Epidemiology. 178:956–961.
- Haack M, Kraus T, Schuld A, et al. (2002). Diurnal variations of interleukin-6 plasma levels are confounded by blood drawing procedures. Psychoneuroendocrinology. 27:921–931.
- Hirshkowitz M, Whiton K, S M Albert, et al. (2015). National Sleep Foundation’s sleep time duration recommendations: Methodology and results summary. Sleep Health. 1:40–43.
- Irwin MR, Olmstead R, Carroll JE. (2015). Sleep disturbance, sleep duration, and inflammation: A systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry. doi:10.1016/j.biopsych.2015.05.014.
- Izawa S, Miki K, Liu X, et al. (2013). The diurnal patterns of salivary interleukin-6 and C-reactive protein in healthy young adults. Brain Behav Immun. 27:38–41.
- Portaluppi F, Smolensky, MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiology Int. 27: 1911–1929.
- de Souza L, Benedito-Silva AA, Pires ML, Poyares D, Tufik S, Calil HM. (2003). Further validation of actigraphy for sleep studies. Sleep. 26:81–85.
- Williamson S, Munro C, Pickler R, et al. (2012). Comparison of biomarkers in blood and saliva in healthy adults. Nurs Res Pract. 246178. doi:10.1155/2012/246178.